DARE logo

Dare Bioscience (DARE) Cash From Operations

Annual CFO

-$38.86 M
-$20.77 M-114.82%

December 31, 2023

Summary

Performance

1-Year Change

-114.82%

3-Year Change

-53.98%

5-Year Change

-278.41%

15-Year Change

-1429.73%

DARE Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.23%
DARE annual cash flow from operations is higher than 33.23% of companies in Healthcare sector

High & Low

All-time High

-$372.30 K

3-Year Low

-$38.86 M
DARE annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
DARE previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
DARE next annual earnings announcement is scheduled for Mar 28, 2025

OtherDAREcash flowmetrics:

Annual CFI

-$629.40 K
DARE annual cash flow from investing activities is -$629.40 thousand

Annual CFF

$15.64 M
DARE annual cash flow from financing activities is $15.64 million

Annual FCF

-$39.49 M
DARE annual free cash flow is -$39.49 million

Annual CAPEX

$629.40 K
DARE annual capital expenditures is $629.40 thousand

Quarterly CFO

-$5.92 M
-$18.83 M-145.91%

September 30, 2024

Summary

Performance

3-Month Change

-145.91%

1-Year Change

+27.57%

3-Year Change

+63.24%

5-Year Change

+63.24%

DARE Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.83%
DARE quarterly cash flow from operations is higher than 41.83% of companies in Healthcare sector

High & Low

All-time High

$24.30 M
DARE quarterly cash flow from operations is currently -124.38% below its historical high of $24.30 million

3-Year Low

-$16.12 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
DARE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
DARE next earnings announcement is scheduled for Mar 28, 2025

OtherDAREcash flowmetrics:

Quarterly CFI

$282.30 K
DARE quarterly cash flow from investing activities is $282.30 thousand

Quarterly CFF

$436.40 K
DARE quarterly cash flow from financing activities is $436.40 thousand

Quarterly FCF

-$5.64 M
DARE quarterly free cash flow is -$5.64 million

Quarterly CAPEX

-$282.30 K
DARE quarterly capital expenditures is -$282.30 thousand

TTM CFO

-$8.01 M
+$2.05 M+20.37%

September 30, 2024

Summary

Performance

3-Month Change

+20.37%

1-Year Change

+79.38%

3-Year Change

+63.36%

5-Year Change

+63.36%

DARE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.87%
DARE TTM cash flow from operations is higher than 62.87% of companies in Healthcare sector

High & Low

All-time High

$23.97 M
DARE TTM cash flow from operations is currently -133.42% below its historical high of $23.97 million

3-Year Low

-$38.86 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
DARE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
DARE next earnings announcement is scheduled for Mar 28, 2025

OtherDAREcash flowmetrics:

TTM CFI

-$617.50 K
DARE TTM cash flow from investing activities is -$617.50 thousand

TTM CFF

$5.88 M
DARE TTM cash flow from financing activities is $5.88 million

TTM FCF

-$8.63 M
DARE TTM free cash flow is -$8.63 million

TTM CAPEX

$617.50 K
DARE TTM capital expenditures is $617.50 thousand

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

DARE Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-114.8%+27.6%+79.4%
3 y3 years-54.0%+63.2%+63.4%
5 y5 years-278.4%+63.2%+63.4%

DARE Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-114.8%at low-145.9%+63.2%at high+79.4%
5 y5-year-191.8%at low-145.9%+63.2%at high+79.4%
alltimeall time<-9999.0%at low-124.4%+63.2%-133.4%+80.3%

Dare Bioscience Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.92 M(-145.9%)
-$8.01 M(-20.4%)
Jun 2024
-
$12.90 M(-289.4%)
-$10.06 M(-66.0%)
Mar 2024
-
-$6.81 M(-16.7%)
-$29.55 M(-23.9%)
Dec 2023
-$38.86 M(+114.8%)
-$8.18 M(+2.6%)
-$38.86 M(+6.2%)
Sep 2023
-
-$7.97 M(+21.1%)
-$36.57 M(+82.9%)
Jun 2023
-
-$6.59 M(-59.1%)
-$20.00 M(-8.5%)
Mar 2023
-
-$16.12 M(+173.3%)
-$21.86 M(+20.9%)
Dec 2022
-$18.09 M(-37.1%)
-$5.90 M(-168.6%)
-$18.09 M(-18.2%)
Sep 2022
-
$8.60 M(-201.8%)
-$22.11 M(-24.8%)
Jun 2022
-
-$8.45 M(-31.6%)
-$29.39 M(-10.2%)
Mar 2022
-
-$12.34 M(+24.5%)
-$32.73 M(+13.8%)
Dec 2021
-$28.76 M(+14.0%)
-$9.92 M(-851.0%)
-$28.76 M(+2.6%)
Sep 2021
-
$1.32 M(-111.2%)
-$28.04 M(-19.2%)
Jun 2021
-
-$11.79 M(+40.8%)
-$34.72 M(+28.5%)
Mar 2021
-
-$8.38 M(-8.9%)
-$27.01 M(+7.1%)
Dec 2020
-$25.23 M(+89.5%)
-$9.19 M(+71.6%)
-$25.23 M(+27.1%)
Sep 2020
-
-$5.36 M(+31.1%)
-$19.85 M(+12.3%)
Jun 2020
-
-$4.09 M(-38.1%)
-$17.67 M(+6.4%)
Mar 2020
-
-$6.60 M(+73.2%)
-$16.60 M(+24.7%)
Dec 2019
-$13.32 M(+29.7%)
-$3.81 M(+19.8%)
-$13.32 M(+9.0%)
Sep 2019
-
-$3.18 M(+5.4%)
-$12.22 M(+3.6%)
Jun 2019
-
-$3.02 M(-8.8%)
-$11.79 M(+2.9%)
Mar 2019
-
-$3.31 M(+22.1%)
-$11.46 M(+11.6%)
Dec 2018
-$10.27 M
-$2.71 M(-1.5%)
-$10.27 M(+20.5%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$2.75 M(+2.3%)
-$8.52 M(+18.5%)
Jun 2018
-
-$2.69 M(+26.9%)
-$7.19 M(+56.0%)
Mar 2018
-
-$2.12 M(+120.5%)
-$4.61 M(+81.4%)
Dec 2017
-$2.54 M(+582.3%)
-$961.10 K(-32.3%)
-$2.54 M(+45.5%)
Sep 2017
-
-$1.42 M(+1194.6%)
-$1.75 M(-107.3%)
Jun 2017
-
-$109.60 K(+116.6%)
$23.97 M(+86.7%)
Mar 2017
-
-$50.60 K(-69.7%)
$12.84 M(-3548.1%)
Dec 2016
-$372.30 K(-98.8%)
-$167.00 K(-100.7%)
-$372.30 K(-95.6%)
Sep 2016
-
$24.30 M(-316.1%)
-$8.42 M(-79.3%)
Jun 2016
-
-$11.24 M(-15.2%)
-$40.68 M(+9.2%)
Mar 2016
-
-$13.26 M(+61.5%)
-$37.23 M(+16.7%)
Dec 2015
-$31.91 M(+67.4%)
-$8.21 M(+3.1%)
-$31.91 M(+8.9%)
Sep 2015
-
-$7.97 M(+2.2%)
-$29.31 M(+9.0%)
Jun 2015
-
-$7.80 M(-1.8%)
-$26.90 M(+15.3%)
Mar 2015
-
-$7.94 M(+41.6%)
-$23.34 M(+22.4%)
Dec 2014
-$19.06 M(+14.7%)
-$5.61 M(+0.9%)
-$19.06 M(+14.0%)
Sep 2014
-
-$5.56 M(+31.4%)
-$16.72 M(+16.3%)
Jun 2014
-
-$4.23 M(+15.4%)
-$14.39 M(-8.2%)
Mar 2014
-
-$3.67 M(+12.1%)
-$15.68 M(-5.6%)
Dec 2013
-$16.61 M(-20.9%)
-$3.27 M(+1.6%)
-$16.61 M(+24.5%)
Sep 2013
-
-$3.22 M(-41.7%)
-$13.34 M(+31.8%)
Jun 2013
-
-$5.52 M(+20.0%)
-$10.12 M(+120.0%)
Mar 2013
-
-$4.60 M
-$4.60 M
Dec 2012
-$21.00 M
-
-

FAQ

  • What is Dare Bioscience annual cash flow from operations?
  • What is the all time high annual CFO for Dare Bioscience?
  • What is Dare Bioscience annual CFO year-on-year change?
  • What is Dare Bioscience quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Dare Bioscience?
  • What is Dare Bioscience quarterly CFO year-on-year change?
  • What is Dare Bioscience TTM cash flow from operations?
  • What is the all time high TTM CFO for Dare Bioscience?
  • What is Dare Bioscience TTM CFO year-on-year change?

What is Dare Bioscience annual cash flow from operations?

The current annual CFO of DARE is -$38.86 M

What is the all time high annual CFO for Dare Bioscience?

Dare Bioscience all-time high annual cash flow from operations is -$372.30 K

What is Dare Bioscience annual CFO year-on-year change?

Over the past year, DARE annual cash flow from operations has changed by -$20.77 M (-114.82%)

What is Dare Bioscience quarterly cash flow from operations?

The current quarterly CFO of DARE is -$5.92 M

What is the all time high quarterly CFO for Dare Bioscience?

Dare Bioscience all-time high quarterly cash flow from operations is $24.30 M

What is Dare Bioscience quarterly CFO year-on-year change?

Over the past year, DARE quarterly cash flow from operations has changed by +$2.25 M (+27.57%)

What is Dare Bioscience TTM cash flow from operations?

The current TTM CFO of DARE is -$8.01 M

What is the all time high TTM CFO for Dare Bioscience?

Dare Bioscience all-time high TTM cash flow from operations is $23.97 M

What is Dare Bioscience TTM CFO year-on-year change?

Over the past year, DARE TTM cash flow from operations has changed by +$30.85 M (+79.38%)